CERTARA INC. - COMMON STOCK
11,09
04-октября-24 15:59:59
15 мин. задержка
Акции
+0,10
+0,91%
Сегодняшний диапазон
11,06 - 11,39
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 окт 2022 07:45:00 Источник Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
31 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Announces Secondary Offering
11 авг 2022 16:38:42 Источник Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2022 Financial Results
09 авг 2022 16:15:01 Источник Nasdaq GlobeNewswire
-
Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
05 авг 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
28 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Appoints Rosemary Crane as New Independent Board Member
25 июл 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Certara Appoints Eran Broshy as New Independent Board Member
13 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
28 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
21 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2022 Financial Results
05 май 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
03 май 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 мар 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
15 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
08 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
21 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Announces Release of Pinnacle 21 Enterprise Software
13 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire